Objective: The pathogenesis of sepsis associated encephalopathy (SAE) remains poorly understood. Vagus nerve plays an important role in gut-microbiota-brain axis. This study aimed to investigate whether vague nerve is a key mediator of the impact of intestinal microbiota on SAE. Methods: Male rats were randomly divided into four groups (n = 20): SHAM (SH) group, lipopolysaccharide (LPS) group, fecal microbiota transplantation (FMT) +LPS group, and vagotomy (VGX) + LPS + FMT group. The left cervical vagotomy was performed 30 min before LPS administration in LPS + FMT + VGX group. LPS+ FMT and LPS + FMT + VGX groups received nasogastric infusion of feces from healthy donor three times a day. Fecal samples were collected every two days to monitor changes in microbiota composition by 16S rDNA analysis. Brain function was evaluated by behavioral tests and EEG. The levels of tumor necrosis factor alpha (TNF-α), interleukin (IL)-1β, IL-6, IL-10 in brain cortex were detected by ELISA. The expression of Iba-1 in brain cortex was assessed by immunohistochemistry and Western blot analysis. Results: Significant modification of microbiota composition, characterized by a profound increase of commensals in the Firmicutes phylum and depletion of opportunistic organisms in the Proteobacteria phylum, was observed in FMT groups compared to LPS group. Furthermore, we identified a reconstituted bacterial community enriched in Firmicutes and depleted of Proteobacteria. In both FMT groups the diversity of the fecal microbiota and the microbiota composition were similar to SH group. LPS mice treated with FMT demonstrated a better spatial memory and less EEG abnormalities, significantly attenuated levels of IL-1β, IL-6, TNF-α, and decreased number of Iba-1 positive microglia in the cortex, but these beneficial effects of FMT were reversed by VGX. Conclusions: FMT can change intestinal microbiota in sepsis patients, and vagus nerve is a key mediator between intestinal microbiota and SAE. These findings suggest that FMT and vagus nerve are potential therapy targets for treating SAE.
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Introduction
Sepsis remains a major clinical challenge in modern medicine and the quality of life among sepsis survivors has now been focused on their brain function [1] . In spite of the absence of direct infection of the central nervous system (CNS), sepsis survivors frequently experience significant neurological morbidity [2, 3] . Brain dysfunction is a major complication of sepsis and is called sepsis-associated encephalopathy (SAE), including delirium, coma, seizure, and focal neurological signs [4] [5] [6] . Despite the high mortality rate and poor prognosis associated with SAE, effective therapy for SAE is still lacking. Currently, SAE treatments focus on controlling the systemic spread of infection and providing supportive therapy [7, 8] . The pathophysiology of SAE is multifactorial and related to the effects of systemic inflammation on cerebral perfusion and neuronal activity, including inflammatory cytokines, microscopic brain injury, blood-brain barrier (BBB) compromise, and altered cerebral metabolism, neurotransmission and cerebral microcirculation [9] [10] [11] . Neuroinflammation is the main mechanisms underlying the development of SAE [12, 13] . Therefore, novel therapeutic strategies for SAE aim to reduce brain inflammation.
The nervous system, via an inflammatory reflex of the vagus nerve, can inhibit cytokine release and prevent tissue injury and death [14, 15] . When pathogens invade the body, inflammatory cytokines are produced and released to solitary the afferent sensory nerve, which in turn activates the efferent vagus nerve, promoting its terminus to release acetylcholine (Ach). Ach then stimulates Ach receptor on the
